Andembry Injection, Solution
Product Images NDC 63833-925

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Andembry (NDC 63833-925). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Csl, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure A (Garadacimab 01)

An instructional diagram showing the ANDEMBRY autoinjector pen before and after use. The diagram highlights components including the clear autoinjector cap, viewing window showing the medicine, plunger stopper, expiration date label, metal part inside cap, gray needle shield, and yellow plunger filling visible in the viewing window after injection, indicating completion. It also notes safety warnings such as not touching the needle shield and that the needle shield locks after use.*

FDA Label Image

Figure B (Garadacimab 02)

Illustration showing components related to the ANDEMBRY 200 mg/1.2 mL injection. The image depicts a single-dose autoinjector labeled as included, along with an alcohol pad, cotton ball, and sharps container, all labeled as required but not included. The autoinjector is shown as a pen-like device with a viewing window.*

FDA Label Image

Figure C (Garadacimab 03)

Illustration showing a subcutaneous injection pen labeled ANDEMBRY, with icons indicating that the device should be kept at room temperature and that a 30-minute waiting period is necessary before use.*

FDA Label Image

Figure D (Garadacimab 04)

An illustration showing a hand holding an injection pen device, presumably for ANDEMBRY (garadacimab) subcutaneous injection. A close-up inset highlights a label area on the device displaying placeholder text for lot number and expiration date.*

FDA Label Image

Figure E (Garadacimab 05)

An instructional line drawing showing a person holding a vertical vial at eye level, aligning their line of sight with a measurement mark on the vial. The illustration likely depicts how to read the liquid level in the vial for correct dosing or inspection.*

FDA Label Image

Figure F (Garadacimab 06)

An instructional illustration showing hands washing under running water from a faucet. One hand holds a bar of soap, demonstrating handwashing technique.*

FDA Label Image

Figure G (Garadacimab 07)

An instructional diagram illustrating recommended injection sites for ANDEMBRY (Garadacimab) subcutaneous injection. The left side shows preferred self-injection sites: the abdomen and outer thighs. The right side shows caregiver injection sites including the outer upper arms, abdomen, and thighs, with shaded areas indicating valid locations for administration.*

FDA Label Image

Figure H (Garadacimab 08)

Illustration showing a person placing a small adhesive patch or dressing on the skin, likely on the abdominal area. The image appears to demonstrate part of the process for administering a subcutaneous injection, related to the ANDEMBRY medication.*

FDA Label Image

Figure I (Garadacimab 09)

An instructional illustration showing two hands holding the ANDEMBRY autoinjector. The left hand is grasping the clear autoinjector cap being pulled off, while the right hand holds the autoinjector body with the gray needle shield. Arrows indicate the direction to remove the autoinjector cap. Labels identify the clear autoinjector cap and gray needle shield with a note not to touch the gray needle shield.*

FDA Label Image

Figure J (Garadacimab 10)

An instructional illustration showing a hand holding an injection device at a 90-degree angle above an arm, demonstrating the proper technique for subcutaneous administration of the injection.*

FDA Label Image

Image (Garadacimab 11)

FDA Label Image

Figure K (Garadacimab 12)

An instructional illustration showing the steps for administering a subcutaneous injection using a device. The series depicts a hand holding the injector with labels indicating the first click, watching a window turn yellow, the second click, and a timer symbol suggesting wait time during administration.*

FDA Label Image

Figure L (Garadacimab 13)

An instructional diagram showing a hand holding an injection pen at a 90-degree angle to the forearm skin, with an arrow indicating upward movement of the pen for subcutaneous injection. The illustration demonstrates the proper injection technique for ANDEMBRY (Garadacimab) 200 mg/1.2mL subcutaneous injection.*

FDA Label Image

Figure M (Garadacimab 14)

An instructional illustration showing hands disposing of a used injection pen and a needle cap into a sharps container labeled "Sharps Container." This image is related to the safe disposal of injection components, relevant for subcutaneous injection administration of ANDEMBRY (garadacimab) injection.*

FDA Label Image

Principal Display Panel (200 mg Pen Label)

Label for ANDEMBRY 200 mg/1.2 mL injection, solution for subcutaneous use as a single-dose prefilled autoinjector. Manufactured by CSL Behring LLC in King of Prussia, PA. The label includes the NDC 63833-925-20, a barcode, and notes to read instructions before use.*

FDA Label Image

Principal Display Panel (200 mg Pen Carton)

Packaging label for ANDEMBRY 200 mg/1.2 mL injection, a subcutaneous autoinjector containing garadacimab-gxii. The label includes the brand and generic names, dosage strength, route of administration, and quantity (single-dose prefilled autoinjector). It is manufactured by CSL Behring, with locations in Germany and the USA, and features storage instructions, barcode, and regulatory information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.